13G Filing: Balyasny Asset Management and Sunesis Pharmaceuticals Inc (SNSS)

Page 1 of 30

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Atlas Master Fund, Ltd 224,506 224,506 224,506 1.05%
Atlas Global 224,506 224,506 224,506 1.05%
Atlas Global Investments, Ltd 224,506 224,506 224,506 1.05%
Atlas Institutional Fund 224,506 224,506 224,506 1.05%
Atlas Institutional Fund, Ltd 224,506 224,506 224,506 1.05%
Atlas Global Japan Unit Trust 224,506 224,506 224,506 1.05%
Atlas Enhanced Master Fund, Ltd 1,310,494 1,310,494 1,310,494 6.11%
Atlas Enhanced Fund 1,310,494 1,310,494 1,310,494 6.11%
Atlas Enhanced Fund, Ltd 1,310,494 1,310,494 1,310,494 6.11%
Atlas Fundamental Trading Master Fund, Ltd 465,000 465,000 465,000 2.17%
Atlas Fundamental Trading Fund 465,000 465,000 465,000 2.17%
Atlas Fundamental Trading Fund, Ltd 465,000 465,000 465,000 2.17%
Balyasny Asset Management 2,000,000 2,000,000 2,000,000 9.32%
Dmitry Balyasny 2,000,000 2,000,000 2,000,000 9.32%

Follow Dmitry Balyasny's Balyasny Asset Management

Page 1 of 30 – SEC Filing

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934

SUNESIS
PHARMACEUTICALS, INC.

(Name of Issuer)

COMMON STOCK

(Title of
Class of Securities)

867328700

(CUSIP Number)

June 23,
2017

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☐ Rule 13d-1(b)


Rule 13d-1(c)

☐ Rule 13d-1(d)

The
information required on the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Follow Viracta Therapeutics Inc. (NASDAQ:VIRX)

Page 1 of 30